(+/-)-Equol ≥98% (par HPLC, TLC)
Marques : Enzo Life SciencesTotal Evaluation: 0
Moyenne des Notes : 0.0 sur 5
Flavonoid. Racemic mixture. Urinary metabolite of daidzein. Inhibits 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 signalling pathway. Shows positive effects on the incidence of prostate cancer and physiological changes after menopause. Functions as a DHT blocker. Preferentially activates estrogen receptor β (ERβ).
- Metabolite of daidzein
Flavonoid. Racemic mixture. Urinary metabolite of daidzein. Inhibits 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 signalling pathway. Shows positive effects on the incidence of prostate cancer and physiological changes after menopause. Functions as a DHT blocker. Preferentially activates estrogen receptor beta (ERbeta).
White to light yellow crystalline solid.
Soluble in DMSO, methanol or 100% ethanol; insoluble in water.
Formule:
C₁₅H₁₄O₃ Poids moléculaire: 242,27 g/mol Température de stockage: Congélateur |
Numéro MDL:
MFCD00016662 Numéro CAS: 94105-90-5 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...